CAPRICOR THERAPEUTICS, INC.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2017 | $-4.7M | $-4.7M | $3.1K | $471.8K |
| Jun 2017 | $-3.7M | $-3.7M | $12.7K | $398.1K |
| Sep 2017 | $-3.2M | $-3.2M | $16.3K | $427.5K |
| Dec 2017 | $-2.7M | $-2.7M | $0 | $413.3K |
| Mar 2018 | $-3.4M | $-3.6M | $186.4K | $457.6K |
| Jun 2018 | $-3.7M | $-3.7M | $238 | $446.7K |
| Sep 2018 | $-3.0M | $-3.1M | $145.5K | $430.4K |
| Dec 2018 | $-3.8M | $-3.8M | $-15.6K | $390.8K |
| Mar 2019 | $-1.6M | $-1.6M | $0 | $223.2K |
| Jun 2019 | $-1.8M | $-1.8M | $0 | $124.2K |
| Sep 2019 | $-1.7M | $-1.7M | $0 | $225.3K |
| Dec 2019 | $-1.8M | $-1.8M | $0 | $128.3K |
| Mar 2020 | $-1.2M | $-1.2M | $0 | $287.8K |
| Jun 2020 | $-2.0M | $-2.1M | $107.5K | $704.4K |
| Sep 2020 | $-3.0M | $-3.1M | $152.0K | $486.8K |
| Dec 2020 | $-3.8M | $-4.1M | $288.1K | $473.7K |
| Mar 2021 | $-3.3M | $-3.4M | $36.9K | $753.0K |
| Jun 2021 | $-4.5M | $-4.8M | $322.5K | $712.3K |
| Sep 2021 | $-3.3M | $-3.8M | $468.2K | $720.3K |
| Dec 2021 | $-5.6M | $-6.0M | $368.7K | $780.2K |
| Mar 2022 | $24.0M | $23.5M | $567.6K | $1.1M |
| Jun 2022 | $-6.5M | $-6.7M | $181.0K | $1.2M |
| Sep 2022 | $-5.7M | $-6.2M | $557.6K | $1.1M |
| Dec 2022 | $-6.9M | $-7.6M | $694.0K | $1.1M |
| Mar 2023 | $4.2M | $3.9M | $347.7K | $2.2M |
| Jun 2023 | $-9.4M | $-9.6M | $135.9K | $1.6M |
| Sep 2023 | $-8.8M | $-9.1M | $269.5K | $1.7M |
| Dec 2023 | $-11.6M | $-12.2M | $558.6K | $1.9M |
| Mar 2024 | $-1.3M | $-1.9M | $608.6K | $3.3M |
| Jun 2024 | $-12.3M | $-12.3M | $60.3K | $2.2M |
| Sep 2024 | $-11.6M | $-11.7M | $9.1K | $2.1M |
| Dec 2024 | $-14.8M | $-15.3M | $488.8K | $2.3M |
| Mar 2025 | $-6.4M | $-7.3M | $896.0K | — |
| Jun 2025 | $-20.1M | $-20.4M | $287.7K | — |
| Sep 2025 | $-19.7M | $-19.7M | $55.8K | — |
| Dec 2025 | $-23.6M | $-25.2M | $1.7M | — |
| Mar 2026 | $-29.3M | $-34.4M | $5.1M | — |
| Jun 2026 | $-31.5M | $-35.5M | $4.1M | — |